Its not onlyfood CEOswho need to worry about their bottom lines thanks to in-demand weight loss drugs like Ozempic.
Big Tobacco and Alcohol have reason to fret, too.
The investment bank also surveyed about 300 GLP-1 users about their consumption habits while taking the medication.
Image: Hollie Adams (Reuters)
But their survey also finds that users are reducing their intake of tobacco and alcohol.
Could weight loss drugs help users smoke or drink less?
Morgan Stanley found similar results when it asked respondents about their use of alcohol.
In addition, Morgan Stanley anticipates the GLP-1 frenzy isnt slowing anytime soon.
global market for GLP-1 drugs will reach $105 billion by 2030.
This article originally appeared onQuartz.
News from the future, delivered to your present.